Skip to Main Content

Author Details

Walead Ebrahimizadeh
Current affiliation: IMV Inc.
2011
24
11
PMIDPaper TitleJournal TitlePublished Year
37037938A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.Br J Cancer2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37126016Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.Clin Cancer Res2023
32763409Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.J Mol Diagn2020
33312216Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function.Res Pharm Sci2020
29144000Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigen.J Cell Biochem2018
29305748Production of human single-chain fragment antibody (ScFv) against human epidermal growth factor receptor-2 (HER-2) by phage display technology.In Vitro Cell Dev Biol Anim2018
28646705Identification and in vitro characterization of novel nanobodies against human granulocyte colony-stimulating factor receptor to provide inhibition of G-CSF function.Biomed Pharmacother2017
29845054Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target.Iran J Biotechnol2017
26767429Selection of Single Chain Antibody Fragments for Targeting Prostate Specific Membrane Antigen: A Comparison Between Cell-based and Antigen-based Approach.Protein Pept Lett2016
24750329Mutational screening of the NR5A1 in azoospermia.Andrologia2015
26775400Immunogenicity of conserved cork and β-barrel domains of baumannii acinetobactin utilization protein in an animal model.Turk J Med Sci2015
26054617Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF.Appl Biochem Biotechnol2015
25250517Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.Microvasc Res2015
24068505A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis.Biotechnol Lett2014
25450883A conserved region from biofilm associated protein as a biomarker for detection of Acinetobacter baumannii.Microb Pathog2014
24638925Bacteriophage vehicles for phage display: biology, mechanism, and application.Curr Microbiol2014
24463583Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.Trans R Soc Trop Med Hyg2014
24425321Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells.Int J Biol Markers2014
23135228Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes.Appl Microbiol Biotechnol2013
23666874In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).Mol Biotechnol2013
23561799A novel nanobody against urease activity of Helicobacter pylori.Int J Infect Dis2013
22806157Inhibition of H. pylori colonization and prevention of gastritis in murine model.World J Microbiol Biotechnol2012
21803146Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin.Microb Pathog2011
  • 1 - 24 of 24

Recommended Authors

Washington University School of Medicine in St. Louis
Career Start Year 2015
Number of shared co-authors 0
Institute of Molecular Biology and Biotechnology, University of Lahore Pakistan.
Career Start Year 2014
Number of shared co-authors 0
KTH - Royal Institute of Technology
Career Start Year 2014
Number of shared co-authors 0
KTH - Royal Institute of Technology
Career Start Year 2005
Number of shared co-authors 0
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Career Start Year 2002
Number of shared co-authors 0
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 1999
Number of shared co-authors 0
Buck Institute for Research on Aging
Career Start Year 1997
Number of shared co-authors 0
College of Science, RMIT University
Career Start Year 1997
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 0
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 0
Technical University of Denmark
Career Start Year 1995
Number of shared co-authors 0
Pfizer Inc.
Career Start Year 1994
Number of shared co-authors 0
University of California San Diego
Career Start Year 1994
Number of shared co-authors 0
Institute of Chemistry, University of Sao Paulo
Career Start Year 1994
Number of shared co-authors 1
School of Pharmacy, University of Waterloo
Career Start Year 1993
Number of shared co-authors 0
The University of Tokyo
Career Start Year 1992
Number of shared co-authors 0
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
KTH Royal Institute of Technology
Career Start Year 1990
Number of shared co-authors 0
Lund University Cancer Centre
Career Start Year 1989
Number of shared co-authors 0
National Institute of Chemistry
Career Start Year 1988
Number of shared co-authors 0
Biodesign Institute, Arizona State University
Career Start Year 1986
Number of shared co-authors 0
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 0
Max-Planck-Institut fur Entwicklungsbiologie
Career Start Year 1984
Number of shared co-authors 0
KTH Royal Institute of Technology
Career Start Year 1981
Number of shared co-authors 0
Linkoping University
Career Start Year 1978
Number of shared co-authors 0
Lund University
Career Start Year 1977
Number of shared co-authors 0
National Centre for Cell Science, SP Pune University Campus
Career Start Year 1977
Number of shared co-authors 0
Monash University
Career Start Year 1971
Number of shared co-authors 0

Collaborators

McGill University Health Centre, McGill University
Co-authored papers 3
Queen's University
Co-authored papers 3
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 3
Research Institute of the McGill University Health Center (RI-MUHC)
Co-authored papers 3
McGill University Health Centre, McGill University
Co-authored papers 3
Queen's University
Co-authored papers 3
University of Edinburgh
Co-authored papers 3
Queen's University
Co-authored papers 3
McGill University Health Centre, McGill University
Co-authored papers 2
University of Toronto
Co-authored papers 1
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 1
Queen's University
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 1
Princess Margaret Hospital, University of Toronto
Co-authored papers 1
Western University and London Regional Cancer Program
Co-authored papers 1
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Research Institute of the McGill University Health Centre
Co-authored papers 1
University of British Columbia
Co-authored papers 1
University of Western Ontario
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Queen's University
Co-authored papers 1
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Kanazawa Medical Center Kanazawa Japan.
Co-authored papers 1
Queen's University Cancer Research Institute
Co-authored papers 1
Queen's University
Co-authored papers 1